Registry and biobank for lymphatic malformations in Italy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This initiative aims to establish a comprehensive registry and biobank for patients with lymphatic malformations (ML) in Italy. It will collect biological samples and clinical data to enhance understanding of ML, including genotype-phenotype associations and the evolution of these conditions over time. The study will also evaluate treatment outcomes and quality of life for affected individuals, while aiming to create a nationally shared diagnostic approach for ML. By gathering this data, the project seeks to improve the management and treatment of patients with these rare conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age 0-100 years
2. Signed informed consent.
3. Individuals with any type of ML (isolated, syndromic, congenital or acquired, with or without molecular confirmation) identified by participating centers

Exclusion Criteria:

* Patients whose clinical picture is not compatible with points a) (b) and (c) of the inclusion criteria, as assessed by the Investigator.

Where it's running

• Department of Woman and Child Health and Public Health, Fondazione Policlinico A. Gemelli, IRCCS
  Roma, Italy Recruiting

Study contacts

• Principal investigator: Chiara Leoni — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
• Study coordinator: Chiara Leoni, MD, PhD
• Email: chiara.leoni@policlinicogemelli.it
• Phone: 00063381344

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Targeted therapies for patients with vascular malformations

  This study is testing new targeted treatments for patients with slow-flow and fast-flow vascular malformations to see if they work better than the usual therapies.

  Recruiting at 2 sites Phase 2 Murdoch Childrens Research Institute · Parkville, Victoria and 1 other locations · NCT05983159

• European registry of lymphatic interventions for people with congenital heart disease or primary lymphatic disorders

  This registry will collect how lymphatic imaging and procedures like embolization are used and see if earlier targeted treatment helps people with congenital heart disease or primary lymphatic disorders.

  Recruiting Copenhagen University Hospital, Rigshospitalet · Copenhagen · NCT07131293

• Using sirolimus to treat cystic lymphatic malformations in children

  This study is testing different doses of sirolimus to see if it can safely help children with cystic lymphatic malformations.

  Recruiting Phase 2/3 West China Hospital · Chengdu, Sichuan · NCT06673290

• Using Bleomycin for treating lymphatic malformations in children

  This study is testing whether different strengths of Bleomycin can safely treat lymphatic malformations in children under 14 that can't be removed with surgery.

  Recruiting Phase 2 West China Hospital · Chengdu, Sichuan · NCT06437158

• Using indocyanine green imaging to treat cystic lymphatic malformation in children

  This study tests if using a special imaging technique can help doctors treat cystic lymphatic malformation in children better than traditional surgery alone.

  Recruiting Nanjing Children's Hospital · Nanjing, Jiangsu · NCT06275022

• Treatment of lymphatic malformations in children using TARA-002

  This study is testing if a new treatment called TARA-002 can safely help reduce lymphatic malformations in children aged 6 months to under 18 years.

  Recruiting at 9 sites Phase 2 Protara Therapeutics · Birmingham, Alabama and 10 other locations · NCT05871970

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.